2XK1
Crystal structure of a complex between Actinomadura R39 DD-peptidase and a boronate inhibitor
Summary for 2XK1
| Entry DOI | 10.2210/pdb2xk1/pdb | 
| Related | 1W79 1W8Q 1W8Y 2VGJ 2VGK 2WKE 2XDM | 
| Descriptor | D-ALANYL-D-ALANINE CARBOXYPEPTIDASE, [(1S)-1-{[(2-benzylphenyl)carbonyl]amino}ethyl](trihydroxy)borate(1-), SULFATE ION, ... (5 entities in total) | 
| Functional Keywords | hydrolase, peptidoglycan | 
| Biological source | ACTINOMADURA SP | 
| Cellular location | Secreted: P39045 | 
| Total number of polymer chains | 4 | 
| Total formula weight | 193561.30 | 
| Authors | Sauvage, E.,Herman, R.,Kerff, F.,Rocaboy, M.,Charlier, P. (deposition date: 2010-07-07, release date: 2011-01-26, Last modification date: 2024-11-13)  | 
| Primary citation | Woon, E.C.Y.,Zervosen, A.,Sauvage, E.,Simmons, K.J.,Ivec, M.,Inglis, S.R.,Fishwick, C.W.G.,Gobec, S.,Charlier, P.,Luxen, A.,Schofield, C.J. Structure Guided Development of Potent Reversibly Binding Penicillin Binding Protein Inhibitors Acs Med.Chem.Lett., 2:219-, 2011 Cited by  PubMed Abstract: Following from the evaluation of different types of electrophiles, combined modeling and crystallographic analyses are used to generate potent boronic acid based inhibitors of a penicillin binding protein. The results suggest that a structurally informed approach to penicillin binding protein inhibition will be useful for the development of both improved reversibly binding inhibitors, including boronic acids, and acylating inhibitors, such as β-lactams. PubMed: 24900305DOI: 10.1021/ML100260X PDB entries with the same primary citation  | 
| Experimental method | X-RAY DIFFRACTION (2.8 Å)  | 
Structure validation
Download full validation report






